Canada Pension Plan Investment Board Acquires New Stake in Humana Inc. $HUM

Canada Pension Plan Investment Board acquired a new stake in Humana Inc. (NYSE:HUM) during the second quarter, Holdings Channel reports. The fund acquired 171,237 shares of the insurance provider’s stock, valued at approximately $68,019,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HUM. Montag A & Associates Inc. grew its holdings in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after buying an additional 94 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in shares of Humana in the second quarter valued at about $26,000. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana in the fourth quarter worth about $27,000. Trust Co. of Vermont purchased a new position in shares of Humana in the second quarter worth about $28,000. Finally, Reflection Asset Management acquired a new position in Humana during the fourth quarter worth about $29,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. UBS Group assumed coverage on shares of Humana in a research note on Thursday, July 30th. They set a “buy” rating for the company. Lake Street Capital assumed coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “buy” rating on the stock. Royal Bank Of Canada boosted their target price on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target for the company in a research report on Wednesday, July 29th. Finally, Zacks Research cut Humana from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $403.91.

Humana Stock Up 0.4%

Shares of NYSE HUM opened at $392.72 on Friday. The company has a 50 day simple moving average of $385.08 and a 200-day simple moving average of $287.78. The company has a market capitalization of $47.16 billion, a P/E ratio of 37.15, a P/E/G ratio of 2.23 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the previous year, the company earned $6.27 EPS. The business’s revenue for the quarter was up 26.2% compared to the same quarter last year. On average, equities research analysts predict that Humana Inc. will post 9.12 earnings per share for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.